Attention deficit hyperactivity disorder: Binding of [99mTc]TRODAT-1 to the dopamine transporter before and after methylphenidate treatment

European Journal of Nuclear Medicine

Volumn 27, Issue 10, 2000, Pages 1518-1524

  Dresel, S ^a   Krause, J ^b   Krause, K H ^b   LaFougere, C ^a   Brinkbaumer K ^a   Kung, H F ^c   Hahn, K ^a   Tatsch, K ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b Outpatient Clinic for Psychiatry and Psychotherapy   (Germany)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

99mTc TRODAT 1; Attention deficit hyperactivity disorder; Methylphenidate

Indexed keywords

FLUORINE 18; FLUORODEOXYGLUCOSE F 18; METIROSINE;

ADOLESCENT; ADULT; AGED; ARTICLE; BONE TUMOR; CANCER DIAGNOSIS; CANCER GRADING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; POSITRON EMISSION TOMOGRAPHY; PROSPECTIVE STUDY; RELIABILITY; SCHOOL CHILD; TUMOR LOCALIZATION; TUMOR VOLUME;

ADULT; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; BRAIN; CARRIER PROTEINS; CAUDATE NUCLEUS; CORPUS STRIATUM; DOPAMINE; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; DOPAMINE UPTAKE INHIBITORS; FEMALE; HUMANS; MALE; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; METHYLPHENIDATE; MIDDLE AGED; NERVE TISSUE PROTEINS; ORGANOTECHNETIUM COMPOUNDS; PUTAMEN; RADIOPHARMACEUTICALS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TROPANES;

EID: 0033770381     PISSN: 03406997     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002590000330     Document Type: Article

References (46)

1. Hyperactivity and conduct problems as risk factors for adolescent development
2. Attention deficit hyperactivity disorder: A category or a continuum? Genetic analysis of a large-scale twin study
3. Childhood hyperactivity scores are highly heritable and show sibling competition effects: Twin study evidence
4. Catecholamines in attention deficit hyperactivity disorder: Current perspectives
5. Confirmation of association between attention deficit hyperactivity disorder and a dopamine transporter polymorphism
6. Mapping susceptibility loci in attention deficit hyperactivity disorder: Preferential transmission of parental alleles at DAT1, DGH and DRD5 to affected children
7. Quantitative morphology of the corpus callosum in attention deficit hyperactivity disorder
8. Brain metabolism in teenagers with attention-deficit hyperactivity disorder
9. High-resolution brain SPECT imaging in ADHD
10. SPECT brain imaging abnormalities in attention deficit hyperactivity disorder
11. 18]DOPA accumulation in children with attention deficit hyperactivity disorder
12. DOPA decarboxylase activity in attention deficit hyperactivity disorder adults. A [fluorine-18]fluorodopa positron emission tomographic study
13. Dopamine transporter density in patients with attention deficit hyperactivity disorder
14. 99mTc]TRODAT-1 to the central dopamine transporters in rats
15. 99mTc]TRODAT-1: A novel technetium-99m complex as a dopamine transporter imaging agent
16. 99mTc]TRODAT-1: A novel compound for imaging the dopamine transporter
17. 99mTc] TRODAT-1 to dopamine transporters in patients with Parkinson's disease and healthy volunteers
18. Effects of age on dopamine transporters in healthy humans
19. Biodistribution and dosimetry of TRODAT-1: A technetium-99m tropane for imaging dopamine transporters
20. Differential diagnosis of ADD versus ADHD in adults
21. The Wender Utah rating scale: An aid in the retrospective diagnosis of childhood attention deficit hyperactivity disorder
22. 99mTc]TRODAT-1 binding to dopamine transporters in non-human primates using SPECT
23. [I-123]IPT SPECT imaging of CNS dopamine transporters: Non-linear effects of normal aging on striatal uptake values
24. 123I]β-CIT: Pharmacological characterization of brain uptake in nonhuman primates
25. Development of PET/SPECT ligands for the serotonin transporter
26. In vivo imaging of dopamine reuptake sites in the primate brain using single photon emission computed tomography (SPECT) and iodine-123 labeled RTI-55
27. 123I]β-CIT SPECT
28. IPT: A novel iodinated ligand for the CNS dopamine transporter
29. Imaging of dopamine transporters with iodine-123-beta-CIT and SPECT in Parkinson's disease
30. 123I]IPT and single-photon emission tomography
31. Imaging dopamine transmission in schizophrenia. A review and meta-analysis
32. Imaging of dopamine transporters in humans with technetium-99m TRODAT-1
33. Simultaneous SPECT studies of pre- and postsynaptic dopamine binding sites in baboons
34. In vivo imaging of serotonin transporters with [Tc-99m]TRODAT-1 in non-human primates
35. Brain morphology in developmental dyslexia and attention deficit disorder/hyperactivity
36. Striatal dysfunction in attention deficit and hyperkinetic disorder
37. Behaviour after neostriatal lesions in animals
38. Effect of methylphenidate on attention in children with attention deficit hyperactivity disorder (ADHD): ERP evidence
39. Response to methylphenidate in boys with attention-deficit hyperactivity disorder
40. Pharmacotherapy of adolescent attention deficit hyperactivity disorder: Challenges, choices and caveats
41. Selective effects of methylphenidate in attention deficit hyperactivity disorder: A functional magnetic resonance study
42. Dopamine transporter occupancies in the human brain induced by therapeutic doses of oral methylphenidate
43. Effects of intravenous dextroamphetamine on brain metabolism in adults with attention-deficit hyperactivity disorder (ADHD). Preliminary findings